Skip to main content
Related Topic: Health


  • Biologics are the fastest growing sector of the prescription drug market.
  • Biosimilars must meet the U.S. Food and Drug Administration’s (FDA) rigorous approval standards before it is considered interchangeable with its biologic reference product.
  • IQVIA estimates that savings from using biosimilars could save up to $183 billion over the next five years.

DO NOT DELETE - NCSL Page Search Data

Related Resources

Lawmakers Turn to Data Systems to Guide Vaccine Decision-Making

As the nation continues to execute the largest immunization campaign in history with COVID-19 vaccines, states have relied on their immunization information systems more than ever to identify trends and inform resource allocation and immunization policies.
  • Contact NCSL

  • For more information on this topic, use this form to reach NCSL staff.